V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002096 | 230011553 | 1.49 | 63.1 | Palliative (P) | null | 2021-10-31 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100069176 |
| 230002117 | 230011556 | 1.62 | 77 | Palliative (P) | 2022-01-28 | 2022-02-11 | null | 2 | null | IPILIMUMAB + NIVOLUMAB | 100477391 |
| 230002124 | 230011558 | 1.63 | 54.7 | Adjuvant (A) | 2020-10-05 | 2020-10-16 | null | null | N | BEVACIZUMAB | 100318201 |
| 230002179 | 230011562 | 1.74 | 56.3 | null | 2021-11-17 | 2022-03-28 | null | null | null | CISPLATIN + GEMCITABINE | 100556662 |
| 230002341 | 230011568 | 1.58 | 73.1 | Palliative (P) | null | 2021-06-21 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101105721 |
| 230002349 | 230011569 | 1.55 | 70.8 | Curative (C) | 2021-07-27 | 2021-08-05 | Cisplatin + Radiotherapy | 02 | null | TRIAL UNSPECIFIED | 100379957 |
| 230002354 | 230011570 | null | 58.5 | Palliative (P) | 2021-10-21 | 2021-11-20 | null | null | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101815667 |
| 230002409 | 230011571 | null | null | null | 2021-01-27 | 2021-03-30 | null | null | null | CISPLATIN | 100843848 |
| 230002456 | 230011575 | 1.63 | 98.3 | null | 2020-09-21 | 2021-05-16 | null | 02 | null | TRASTUZUMAB EMTANSINE | 101871570 |
| 230002457 | 230011576 | 1.54 | 93.4 | Palliative (P) | 2021-12-17 | 2022-01-17 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100471205 |
| 230002462 | 230011578 | 1.65 | 65.6 | null | 2021-06-19 | 2021-06-19 | null | null | null | CISPLATIN + PACLITAXEL | 100217599 |
| 230001673 | 230011586 | 1.59 | 75 | null | null | 2019-08-05 | Niraparib | 02 | null | NIRAPARIB | 101631811 |
| 230001135 | 230011630 | null | null | null | null | 2021-08-24 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100186203 |
| 230001145 | 230011631 | null | null | null | null | 2021-10-27 | null | null | null | CARBOPLATIN + PACLITAXEL | 101777462 |
| 230001173 | 230011632 | null | null | null | 2022-03-17 | 2022-04-11 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100000472 |
| 230001235 | 230011636 | 1.61 | null | null | 2021-12-03 | 2021-12-04 | Carboplatin 21day + Paclitaxel 7day | null | null | CARBOPLATIN + PACLITAXEL | 101312298 |
| 230001339 | 230011639 | 1.61 | null | null | 2021-12-07 | 2021-12-25 | null | null | null | CARBOPLATIN + PACLITAXEL | 101049833 |
| 230001361 | 230011644 | 1.7 | 61.4 | Palliative (P) | 2019-03-09 | 2019-03-10 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100539577 |
| 230001382 | 230011646 | 1.51 | 47.8 | null | null | 2021-09-27 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101834209 |
| 230001430 | 230011651 | 1.48 | 54 | null | 2022-04-18 | 2022-04-18 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101396392 |
| 230001520 | 230011655 | 1.53 | 101 | null | 2022-04-07 | 2022-04-22 | null | null | null | NIRAPARIB | 100488711 |
| 230001528 | 230011656 | 1.64 | 60.7 | null | 2020-04-10 | 2020-04-17 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 100311026 |
| 230001590 | 230011657 | 1.7 | 91.8 | Palliative (P) | 2022-01-25 | 2022-02-03 | Bevacizumab | 02 | N | BEVACIZUMAB | 100381159 |
| 230001620 | 230011658 | 1.6 | 79.7 | Neo-adjuvant (N) | 2022-04-27 | 2022-05-12 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100388675 |
| 230001653 | 230011659 | null | null | null | 2019-02-10 | 2019-05-14 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101812817 |
| 230001662 | 230011660 | 1.57 | 69.8 | Palliative (P) | 2018-07-01 | 2018-07-08 | Rucaparib | 02 | N | RUCAPARIB | 100739333 |
| 230001668 | 230011661 | null | null | null | null | 2022-05-20 | NIVOLUMAB | 02 | null | CISPLATIN + ETOPOSIDE | 101809469 |
| 230001706 | 230011664 | null | null | null | 2022-04-12 | 2022-04-16 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100983724 |
| 230001742 | 230011666 | 1.62 | 79.2 | null | 2017-04-17 | 2017-04-18 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100341122 |
| 230001780 | 230011668 | 1.62 | 74.6 | null | null | 2021-08-02 | Rucaparib | 02 | null | RUCAPARIB | 101475987 |
| 230001787 | 230011669 | 1.61 | 84 | null | 2020-10-12 | 2020-10-19 | null | null | null | BEVACIZUMAB + CARBO + PACLITAXEL | 101286448 |
| 230001809 | 230011670 | 1.59 | 55.7 | null | 2020-12-15 | 2020-12-30 | Bevacizumab | 02 | null | BEVACIZUMAB | 100132664 |
| 230001815 | 230011672 | 1.57 | 59 | null | 2021-01-17 | 2021-01-30 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101779065 |
| 230001835 | 230011673 | 1.63 | 86.4 | null | 2021-12-07 | 2021-12-07 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101058651 |
| 230001880 | 230011675 | 1.6 | 76 | null | 2021-07-08 | 2021-11-04 | null | 01 | null | NIVOLUMAB | 101351228 |
| 230001939 | 230011677 | 1.67 | 74 | Palliative (P) | 2017-04-27 | 2019-01-22 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100510619 |
| 230001955 | 230011680 | null | 53 | null | null | 2021-06-18 | PACLITAXEL | 02 | null | PACLITAXEL | 100203421 |
| 230001982 | 230011681 | 1.62 | 68.4 | null | 2018-10-16 | 2018-11-01 | null | null | null | BEVACIZUMAB | 101163629 |
| 230002050 | 230011683 | 1.57 | 60 | Curative (C) | 2019-08-11 | 2019-10-08 | null | null | N | IPILIMUMAB + NIVOLUMAB | 101559296 |
| 230002067 | 230011684 | 1.68 | 100 | Neo-adjuvant (N) | null | 2021-04-07 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101408196 |
| 230002078 | 230011685 | 1.67 | 74 | null | null | 2021-06-01 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101221344 |
| 230002164 | 230011690 | 1.76 | 97.6 | null | 2021-08-08 | 2021-08-08 | null | null | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100317806 |
| 230002179 | 230011691 | 1.63 | 123.7 | null | 2022-05-12 | 2022-05-12 | Niraparib | 02 | null | NIRAPARIB | 100556662 |
| 230002219 | 230011692 | 1.66 | 76.4 | null | 2021-11-04 | 2022-02-14 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 100788570 |
| 230002341 | 230011696 | 1.63 | 60.2 | null | null | 2021-07-09 | null | null | null | PACLITAXEL | 101105721 |
| 230002349 | 230011697 | 1.61 | 89.6 | 03 | null | 2021-09-08 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100379957 |
| 230002354 | 230011698 | 1.62 | 66.4 | null | 2021-11-20 | 2021-11-20 | Rucaparib | 02 | null | RUCAPARIB | 101815667 |
| 230002412 | 230011700 | 1.5 | 43.2 | Palliative (P) | null | 2021-01-22 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101528187 |
| 230002457 | 230011703 | 1.47 | 94 | null | 2020-12-13 | 2022-02-09 | Niraparib | 02 | null | NIRAPARIB | 100471205 |
| 230002460 | 230011704 | 1.51 | 52.75 | Neo-adjuvant (N) | 2020-05-13 | 2020-06-11 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100702198 |